Aucun résultat
Dr. Shireen Sirhan co-established the first Myeloproliferative Neoplasms (MPN) clinic in Canada at the Jewish General Hospital, where specialized multidisciplinary care and access to specialised testing and clinical trials is offered. She is the principal investigator on several clinical trials that have helped providing access to novel agents in the field of MPNs.
She is a founding member and the current President of the Canadian MPN group, and Vice-President for research in MPNs of the Groupe Québécois de recherche en LMC-NMP. She also serves as member of advisory board for Canadian MPN Research Foundation.
Research interests include:
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media
